MedPath

Data Collection Study of Sporit GG

Phase 4
Completed
Conditions
Health Condition 1: R197- Diarrhea, unspecified
Registration Number
CTRI/2020/03/023736
Lead Sponsor
Sun Pharmaceutical Industries Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

Patients will be eligible for treatment with Sporit GG, as per the treating doctor.

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration and frequency of diarrhea.Timepoint: Day 1,2,3,4,5 and 6
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath